|
Empowering pathologists to lead immuno-oncology (IO) biomarker testing in the community
Journal of Clinical Oncology doi.org/10.1200/JCO.2022.40.28_suppl.348 Leveraging continuing education and implementation science approaches to improve the care of patients with myeloproliferative neoplasms Journal of Clinical Oncology doi.org/10.1200/JCO.2022.40.28_suppl.334 Reducing preventable ED visits in patients with advanced NSCLC: Collective insights from three cancer centers Journal of Clinical Oncology doi.org/10.1200/JCO.2022.40.28_suppl.337 A mixed-methods study to identify key priorities around improving team-based care coordination for patients receiving combination IV and oral systemic anti-cancer therapy Journal of Clinical Oncology doi.org/10.1200/JCO.2022.40.28_suppl.052 Association of Community Cancer Centers key quality care recommendations for stage IB to IIIA non–small cell lung cancer Journal of Clinical Oncology doi.org/10.1200/JCO.2022.40.28_suppl.030 Comments are closed.
|
Author@DrJosephKim Sign up to receive updates:
|
